BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wozel G, Blasum C. Dapsone in dermatology and beyond. Arch Dermatol Res 2014;306:103-24. [PMID: 24310318 DOI: 10.1007/s00403-013-1409-7] [Cited by in Crossref: 160] [Cited by in F6Publishing: 121] [Article Influence: 20.0] [Reference Citation Analysis]
Number Citing Articles
1 Gul J, Ullah S, Ali I, Rao K, Iqbal KM, Jabri T, Perveen S, Rashid A, Shah MR. Synthesis, characterization and drug delivery application of Dapsone based double tailed biocompatible nonionic surfactant. Chem Phys Lipids 2021;239:105115. [PMID: 34252425 DOI: 10.1016/j.chemphyslip.2021.105115] [Reference Citation Analysis]
2 Murthy S, Schilf P, Patzelt S, Thieme M, Becker M, Kröger L, Bremer T, Derenda-Hell A, Knebel L, Fagiani F, Ibrahim SM, Schmidt E, Zillikens D, Sadik CD. Dapsone Suppresses Disease in Preclinical Murine Models of Pemphigoid Diseases. J Invest Dermatol 2021:S0022-202X(21)01216-1. [PMID: 34033839 DOI: 10.1016/j.jid.2021.04.009] [Reference Citation Analysis]
3 Juratli HA, Görög A, Sárdy M. [Dermatitis herpetiformis]. Hautarzt 2019;70:260-4. [PMID: 30868254 DOI: 10.1007/s00105-019-4378-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Yamasaki PR, do Nascimento DC, Chelucci RC, de Faria Fernandes Belone A, Rosa PS, Diório SM, de Melo TRF, Barbieri KP, Placeres MCP, Carlos IZ, Chung MC, dos Santos JL. Synthesis and evaluation of novel dapsone–thalidomide hybrids for the treatment of type 2 leprosy reactions. Bioorganic & Medicinal Chemistry Letters 2014;24:3084-7. [DOI: 10.1016/j.bmcl.2014.05.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
5 Ly KH, Dalmay F, Gondran G, Palat S, Bezanahary H, Cypierre A, Fauchais AL, Liozon E. Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients. Medicine (Baltimore) 2016;95:e4974. [PMID: 27759628 DOI: 10.1097/MD.0000000000004974] [Cited by in Crossref: 19] [Cited by in F6Publishing: 7] [Article Influence: 4.8] [Reference Citation Analysis]
6 Schneider-Rauber G, Argenta DF, Caon T. Emerging Technologies to Target Drug Delivery to the Skin - the Role of Crystals and Carrier-Based Systems in the Case Study of Dapsone. Pharm Res 2020;37:240. [PMID: 33169237 DOI: 10.1007/s11095-020-02951-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Rohit Singh T, Ezhilarasan D. Lagerstroemia speciosa (L.) Pers., ethanolic extract attenuates simultaneously administered isoniazid- and dapsone-induced hepatotoxicity in rats. J Food Biochem 2021;:e13830. [PMID: 34155655 DOI: 10.1111/jfbc.13830] [Reference Citation Analysis]
8 Markidan J, Pfau R, Drachenberg C, Stashek K. Educational Case: Dermatitis Herpetiformis. Acad Pathol 2021;8:23742895211006844. [PMID: 33889719 DOI: 10.1177/23742895211006844] [Reference Citation Analysis]
9 Kwon MJ, Joo HG. Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production. J Vet Sci 2018;19:744-9. [PMID: 30304888 DOI: 10.4142/jvs.2018.19.6.744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Akinsomisoye OS, Gupta G, Raji Y. Experimental dapsone administration induces infertility in male Wistar rats: Mechanisms and clinical implications. Pathophysiology 2019;26:289-303. [PMID: 31387782 DOI: 10.1016/j.pathophys.2019.07.004] [Reference Citation Analysis]
11 Molinelli E, Paolinelli M, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues surrounding dapsone. Expert Opinion on Drug Metabolism & Toxicology 2019;15:367-79. [DOI: 10.1080/17425255.2019.1600670] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
12 Kast RE. Dapsone as treatment adjunct in ARDS. Exp Lung Res 2020;46:157-61. [PMID: 32286085 DOI: 10.1080/01902148.2020.1753266] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
13 Blaskovich MAT, Elliott AG, Kavanagh AM, Ramu S, Cooper MA. In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria. Sci Rep 2019;9:14658. [PMID: 31601845 DOI: 10.1038/s41598-019-50746-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
14 Kast RE. Erlotinib augmentation with dapsone for rash mitigation and increased anti-cancer effectiveness. Springerplus 2015;4:638. [PMID: 26543772 DOI: 10.1186/s40064-015-1441-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sabbadin C, Andrisani A, Donà G, Tibaldi E, Brunati AM, Dall'Acqua S, Ragazzi E, Ambrosini G, Armanini D, Bordin L. Endometriosis Susceptibility to Dapsone-Hydroxylamine-Induced Alterations Can Be Prevented by Licorice Intake: In Vivo and In Vitro Study. Int J Mol Sci 2021;22:8476. [PMID: 34445180 DOI: 10.3390/ijms22168476] [Reference Citation Analysis]
16 Kuhn A, Aberer E, Bata-Csörgő Z, Caproni M, Dreher A, Frances C, Gläser R, Klötgen HW, Landmann A, Marinovic B, Nyberg F, Olteanu R, Ranki A, Szepietowski JC, Volc-Platzer B. S2k guideline for treatment of cutaneous lupus erythematosus - guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV). J Eur Acad Dermatol Venereol 2017;31:389-404. [PMID: 27859683 DOI: 10.1111/jdv.14053] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 11.8] [Reference Citation Analysis]
17 Sheibani M, Nezamoleslami S, Faghir-ghanesefat H, Emami AH, Dehpour AR. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats. Cancer Chemother Pharmacol 2020;85:563-71. [DOI: 10.1007/s00280-019-04019-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
18 Hill QA. How does dapsone work in immune thrombocytopenia? Implications for dosing. Blood 2015;125:3666-8. [DOI: 10.1182/blood-2015-03-632000] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
19 Boccellino M, Quagliuolo L, Alaia C, Grimaldi A, Addeo R, Nicoletti GF, Kast RE, Caraglia M. The strange connection between epidermal growth factor receptor tyrosine kinase inhibitors and dapsone: from rash mitigation to the increase in anti-tumor activity. Current Medical Research and Opinion 2016;32:1839-48. [DOI: 10.1080/03007995.2016.1211522] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
20 Mohammad Jafari R, Shayesteh S, Ala M, Yousefi-Manesh H, Rashidian A, Hashemian SM, Sorouri M, Dehpour AR. Dapsone Ameliorates Colitis through TLR4/NF-kB Pathway in TNBS Induced Colitis Model in Rat. Arch Med Res 2021;52:595-602. [PMID: 33814208 DOI: 10.1016/j.arcmed.2021.03.005] [Reference Citation Analysis]
21 Kast RE, Hill QA, Wion D, Mellstedt H, Focosi D, Karpel-massler G, Heiland T, Halatsch M. Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin. Tumour Biol 2017;39:101042831769979. [DOI: 10.1177/1010428317699797] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 5.8] [Reference Citation Analysis]
22 Watanabe J, Shimamoto J, Kotani K. The Effects of Antibiotics for Helicobacter pylori Eradication or Dapsone on Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2021;10:156. [PMID: 33557074 DOI: 10.3390/antibiotics10020156] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Choi H, Cho SC, Ha YW, Ocampo B, Park S, Chen S, Bennett CF, Han J, Rossner R, Kang JS, Lee YL, Park SC, Kaeberlein M. DDS promotes longevity through a microbiome-mediated starvation signal. Transl Med Aging 2019;3:64-9. [PMID: 32190786 DOI: 10.1016/j.tma.2019.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kast RE. Paths for Improving Bevacizumab Available in 2018: The ADZT Regimen for Better Glioblastoma Treatment. Med Sci (Basel) 2018;6:E84. [PMID: 30274295 DOI: 10.3390/medsci6040084] [Reference Citation Analysis]
25 Garcia D, Cohen PR. Dapsone-associated fixed drug eruption. Expert Rev Clin Pharmacol 2017;10:717-25. [PMID: 28434260 DOI: 10.1080/17512433.2017.1322508] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Nedosekin D, Wilson KD, Campbell K, Shalin S, Wong HK. Immunologic overlap in a case of linear IgG/IgA bullous dermatosis responsive to rituximab. JAAD Case Rep 2021;9:57-60. [PMID: 33665277 DOI: 10.1016/j.jdcr.2020.12.029] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Wu M, Hu W, Wang G, Yao Y, Yu XF. Nicotinamide N-Methyltransferase Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer. Front Genet 2020;11:580299. [PMID: 33193702 DOI: 10.3389/fgene.2020.580299] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Braun DE, Griesser UJ. Supramolecular Organization of Nonstoichiometric Drug Hydrates: Dapsone. Front Chem 2018;6:31. [PMID: 29520359 DOI: 10.3389/fchem.2018.00031] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
29 Vale ECSD, Dimatos OC, Porro AM, Santi CG. Consensus on the treatment of autoimmune bullous dermatoses: dermatitis herpetiformis and linear IgA bullous dermatosis - Brazilian Society of Dermatology. An Bras Dermatol 2019;94:48-55. [PMID: 31166403 DOI: 10.1590/abd1806-4841.2019940208] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
30 Tiwari R, Tiwari G, Wal P, Wal A, Maurya P. Development, Characterization and Transdermal Delivery of Dapsone and an Antibiotic Entrapped in Ethanolic Liposomal Gel for the Treatment of Lapromatous Leprosy. TONMJ 2018;5:1-15. [DOI: 10.2174/1875933501805010001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
31 Alimohammadi A, Mostafavi H, Mahdavi M. Thiourea Derivatives Based on the Dapsone‐Naphthoquinone Hybrid as Anticancer and Antimicrobial Agents: In Vitro Screening and Molecular Docking Studies. ChemistrySelect 2020;5:847-52. [DOI: 10.1002/slct.201903179] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
32 Machado S, Fernandes SR, Chaves LL, Lima SAC, Silva EMP, Barreiros L, Reis S, Segundo MA. Chromatographic method for the simultaneous quantification of dapsone and clofazimine in nanoformulations. J Sep Sci 2018;41:3382-8. [DOI: 10.1002/jssc.201800427] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
33 Taraghikhah N, Ashtari S, Asri N, Shahbazkhani B, Al-Dulaimi D, Rostami-Nejad M, Rezaei-Tavirani M, Razzaghi MR, Zali MR. An updated overview of spectrum of gluten-related disorders: clinical and diagnostic aspects. BMC Gastroenterol 2020;20:258. [PMID: 32762724 DOI: 10.1186/s12876-020-01390-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 19.0] [Reference Citation Analysis]
34 Song J. Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar. Blood Res 2017;52:77-8. [PMID: 28698839 DOI: 10.5045/br.2017.52.2.77] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Satapornpong P, Pratoomwun J, Rerknimitr P, Klaewsongkram J, Nakkam N, Rungrotmongkol T, Konyoung P, Saksit N, Mahakkanukrauh A, Amornpinyo W, Khunarkornsiri U, Tempark T, Wantavornprasert K, Jinda P, Koomdee N, Jantararoungtong T, Rerkpattanapipat T, Wang CW, Naisbitt D, Tassaneeyakul W, Ariyachaipanich M, Roonghiranwat T, Pirmohamed M, Chung WH, Sukasem C. HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Front Immunol 2021;12:661135. [PMID: 34017337 DOI: 10.3389/fimmu.2021.661135] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wohlrab J, Michael J. Dapsone for topical use in extemporaneous preparations. J Dtsch Dermatol Ges 2018;16:34-40. [PMID: 29280553 DOI: 10.1111/ddg.13409] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Spring IR, Ilangaratne C, Walsh S. HbA1c levels: falsely low in a patient taking dapsone. Clin Exp Dermatol 2021;46:346-7. [PMID: 32575170 DOI: 10.1111/ced.14343] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Abdelzaher WY, Ahmed SM, Welson NN, Alsharif KF, Batiha GE, Labib DAA. Dapsone Ameliorates Isoproterenol-Induced Myocardial Infarction via Nrf2/ HO-1; TLR4/ TNF-α Signaling Pathways and the Suppression of Oxidative Stress, Inflammation, and Apoptosis in Rats. Front Pharmacol 2021;12:669679. [PMID: 34093197 DOI: 10.3389/fphar.2021.669679] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Goldust M, Hartmann K, Abdelmaksoud A, Navarini AA. Utility and risk of dermatologic medications during the COVID-19 pandemic. Dermatol Ther 2020;33:e13833. [PMID: 32537852 DOI: 10.1111/dth.13833] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Laufer Britva R, Amber K, Cohen A, Kridin K. Treatment and clinical outcomes in anti‐p200 pemphigoid: a systematic review. J Eur Acad Dermatol Venereol 2019;34:465-72. [DOI: 10.1111/jdv.15961] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Rashdan HRM, Shehadi IA, Abdelrahman MT, Hemdan BA. Antibacterial Activities and Molecular Docking of Novel Sulfone Biscompound Containing Bioactive 1,2,3-Triazole Moiety. Molecules 2021;26:4817. [PMID: 34443405 DOI: 10.3390/molecules26164817] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Parvathaneni V, Kulkarni NS, Muth A, Gupta V. Drug repurposing: a promising tool to accelerate the drug discovery process. Drug Discov Today 2019;24:2076-85. [PMID: 31238113 DOI: 10.1016/j.drudis.2019.06.014] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 23.5] [Reference Citation Analysis]
43 Braun DE, Vickers M, Griesser UJ. Dapsone Form V: A Late Appearing Thermodynamic Polymorph of a Pharmaceutical. Mol Pharm 2019;16:3221-36. [PMID: 31075201 DOI: 10.1021/acs.molpharmaceut.9b00419] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
44 Chang VS, Chodosh J, Papaliodis GN. Chronic Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: The Role of Systemic Immunomodulatory Therapy. Semin Ophthalmol 2016;31:178-87. [PMID: 26959145 DOI: 10.3109/08820538.2015.1114841] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
45 Khandalavala BN. A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report. Case Rep Dermatol 2017;9:70-8. [PMID: 28868004 DOI: 10.1159/000473873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
46 Graziano M, Rossi M. An update on the cutaneous manifestations of coeliac disease and non-coeliac gluten sensitivity. Int Rev Immunol. 2018;37:291-300. [PMID: 30516407 DOI: 10.1080/08830185.2018.1533008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
47 Rohit Singh T, Ezhilarasan D. Lagerstroemia speciosa (L.) Pers., ethanolic leaves extract attenuates dapsone-induced liver inflammation in rats. Drug Chem Toxicol 2021;:1-10. [PMID: 34225555 DOI: 10.1080/01480545.2021.1945079] [Reference Citation Analysis]
48 Zampella JG, Vakili S, Doig S, Girardi N, Kwatra SG, Seo P, Patel M. Macular lymphocytic arteritis: Clinical-pathologic correlation of a rare vasculitis. JAAD Case Rep 2017;3:116-20. [PMID: 28337473 DOI: 10.1016/j.jdcr.2017.01.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
49 Ríos C, Farfán-briseño AC, Manjarrez-marmolejo J, Franco-pérez J, Méndez-armenta M, Nava-ruiz C, Caballero-chacón S, Ruiz-diaz A, Baron-flores V, Díaz-ruiz A. Efficacy of dapsone administered alone or in combination with diazepam to inhibit status epilepticus in rats. Brain Research 2019;1708:181-7. [DOI: 10.1016/j.brainres.2018.12.017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
50 Görög A, Németh K, Szabó L, Mayer B, Silló P, Kolev K, Kárpáti S. Decreased fibrinolytic potential and morphological changes of fibrin structure in dermatitis herpetiformis. Journal of Dermatological Science 2016;84:17-23. [DOI: 10.1016/j.jdermsci.2016.07.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ríos C, Orozco-suarez S, Salgado-ceballos H, Mendez-armenta M, Nava-ruiz C, Santander I, Barón-flores V, Caram-salas N, Diaz-ruiz A. Anti-Apoptotic Effects of Dapsone After Spinal Cord Injury in Rats. Neurochem Res 2015;40:1243-51. [DOI: 10.1007/s11064-015-1588-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
52 Sacchidanand SA, Lahiri K, Godse K, Patwardhan NG, Ganjoo A, Kharkar R, Narayanan V, Borade D, D'souza L. Synchronizing Pharmacotherapy in Acne with Review of Clinical Care. Indian J Dermatol 2017;62:341-57. [PMID: 28794543 DOI: 10.4103/ijd.IJD_41_17] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
53 Shamma RN, Salah Ad-din I, Abdeltawab NF. Dapsone- gel as a novel platform for acne treatment: In vitro evaluation and In vivo performance and histopathological studies in acne infected mice. Journal of Drug Delivery Science and Technology 2019;54:101238. [DOI: 10.1016/j.jddst.2019.101238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Moreno E, Calvo A, Schwartz J, Navarro-Blasco I, González-Peñas E, Sanmartín C, Irache JM, Espuelas S. Evaluation of Skin Permeation and Retention of Topical Dapsone in Murine Cutaneous Leishmaniasis Lesions. Pharmaceutics 2019;11:E607. [PMID: 31766282 DOI: 10.3390/pharmaceutics11110607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
55 Guglielmetti A, Jahr C, Gompertz-Mattar M. Autologous fibroblasts for the treatment of cutaneous loxoscelism: First experience. Int Wound J 2019;16:1503-5. [PMID: 31531944 DOI: 10.1111/iwj.13222] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Salmaninejad A, Gowhari A, Hosseini S, Aslani S, Yousefi M, Bahrami T, Ebrahimi M, Nesaei A, Zal M. Genetics and immunodysfunction underlying Behçet's disease and immunomodulant treatment approaches. J Immunotoxicol 2017;14:137-51. [PMID: 28693405 DOI: 10.1080/1547691X.2017.1346008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 5.3] [Reference Citation Analysis]
57 Chen Z, Liu N, Bolte M, Ren H, Manolikakes G. Visible-light mediated 3-component synthesis of sulfonylated coumarins from sulfur dioxide. Green Chem 2018;20:3059-70. [DOI: 10.1039/c8gc00838h] [Cited by in Crossref: 54] [Article Influence: 18.0] [Reference Citation Analysis]
58 Fernando M, Kankananarachchi I, Navabalasooriyar P, Herath B, Punchihewa P. A Case of Dapsone-Induced Severe Agranulocytosis Causing Life-Threatening Skin Sepsis in a Sri Lankan Child with Borderline Leprosy: A Success Story! Case Rep Med 2019;2019:2314379. [PMID: 31198424 DOI: 10.1155/2019/2314379] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 Deckers IE, Prens EP. An Update on Medical Treatment Options for Hidradenitis Suppurativa. Drugs 2016;76:215-29. [PMID: 26659474 DOI: 10.1007/s40265-015-0516-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
60 El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay. AAPS PharmSciTech 2018;19:2174-84. [PMID: 29725903 DOI: 10.1208/s12249-018-1025-0] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
61 Corallo C, Coutsouvelis J, Avery S, Morgan S, Morrissey O. Dapsone and azole interactions: A clinical perspective. J Oncol Pharm Pract 2018;24:637-40. [DOI: 10.1177/1078155217722048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
62 Liu M, Huang YYM, Hsu S, Kass JS. Neurological and Neuropsychiatric Adverse Effects of Dermatologic Medications. CNS Drugs 2016;30:1149-68. [DOI: 10.1007/s40263-016-0392-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
63 Membrive Jiménez C, Pérez Ramírez C, Sánchez Martín A, Vieira Maroun S, Arias Santiago S, Ramírez Tortosa MC, Jiménez Morales A. Clinical Application of Pharmacogenetic Markers in the Treatment of Dermatologic Pathologies. Pharmaceuticals (Basel) 2021;14:905. [PMID: 34577605 DOI: 10.3390/ph14090905] [Reference Citation Analysis]
64 Wang C, Li Q, Li T. Dioscin alleviates lipopolysaccharide-induced acute lung injury through suppression of TLR4 signaling pathways. Exp Lung Res 2020;46:11-22. [PMID: 31931639 DOI: 10.1080/01902148.2020.1711830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
65 Gunawardena S, Kapilananda GM, Samarakoon D, Maddevithana S, Wijesundera S, Goonaratne LV, Karunaweera ND. Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka. PLoS One 2017;12:e0171208. [PMID: 28152025 DOI: 10.1371/journal.pone.0171208] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Afshari K, Momeni Roudsari N, Lashgari NA, Haddadi NS, Haj-Mirzaian A, Hassan Nejad M, Shafaroodi H, Ghasemi M, Dehpour AR, Abdolghaffari AH. Antibiotics with therapeutic effects on spinal cord injury: a review. Fundam Clin Pharmacol 2021;35:277-304. [PMID: 33464681 DOI: 10.1111/fcp.12605] [Reference Citation Analysis]
67 Gooderham MJ, Van Voorhees AS, Lebwohl MG. An update on generalized pustular psoriasis. Expert Rev Clin Immunol. 2019;15:907-919. [PMID: 31486687 DOI: 10.1080/1744666x.2019.1648209] [Cited by in Crossref: 30] [Cited by in F6Publishing: 5] [Article Influence: 15.0] [Reference Citation Analysis]
68 Khandalavala BN, Nirmalraj MC. Rapid partial repigmentation of vitiligo in a young female adult with a gluten-free diet. Case Rep Dermatol 2014;6:283-7. [PMID: 25685131 DOI: 10.1159/000370303] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
69 Pichler M, Thuile T, Gatscher B, Tappeiner L, Deluca J, Larcher L, Holzer M, Nguyen V, Exler G, Schmuth M, Klein G, Eisendle K. Systematic review of surgical treatment of pyoderma gangrenosum with negative pressure wound therapy or skin grafting. J Eur Acad Dermatol Venereol 2017;31:e61-7. [DOI: 10.1111/jdv.13727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
70 Ghaoui N, Hanna E, Abbas O, Kibbi AG, Kurban M. Update on the use of dapsone in dermatology. Int J Dermatol 2020;59:787-95. [PMID: 31909480 DOI: 10.1111/ijd.14761] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
71 Liu H, Wang Z, Bao F, Wang C, Sun L, Zhang H, Yu G, Mi Z, Li J, Li L, Zhao Q, Yue Z, Zhao W, Yu W, Cao J, Xiong F, Wang Y, Chai Z, Cheng X, Zhang Y, Fu F, Lang X, Wang X, Irwanto A, Krismawati H, Fu X, Sun Y, You J, Liu J, Pan Q, Chu T, Liu D, Chen S, Shen J, Yan L, Zhang G, Liu J, Zhang F, Xiong L, Yang J, Li J, Ke W, Li M, Ning Y, Xiong J, Li M, Xiong M, Yang B, Duan Q, Wang H, Li W, Kuang Y, Li J, Wang L, Cao Q, Xiao P, Xiao B, Zhang L, Lin Z, Wang Y, Shen Y, Yan L, Wu W, Zheng H, Zhan X, Li W, Shang X, Xu Y, Liu Q; Dapsone Hypersensitivity Syndrome Prevention Working Group. Evaluation of Prospective HLA-B*13:01 Screening to Prevent Dapsone Hypersensitivity Syndrome in Patients With Leprosy. JAMA Dermatol 2019;155:666-72. [PMID: 30916737 DOI: 10.1001/jamadermatol.2018.5360] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
72 Chakraborty A, Panda AK, Ghosh R, Biswas A. DNA minor groove binding of a well known anti-mycobacterial drug dapsone: A spectroscopic, viscometric and molecular docking study. Arch Biochem Biophys 2019;665:107-13. [PMID: 30851241 DOI: 10.1016/j.abb.2019.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
73 Frew JW, Hawkes JE, Krueger JG. Topical, systemic and biologic therapies in hidradenitis suppurativa: pathogenic insights by examining therapeutic mechanisms. Ther Adv Chronic Dis 2019;10:2040622319830646. [PMID: 30854183 DOI: 10.1177/2040622319830646] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 14.0] [Reference Citation Analysis]
74 Lee KH, Park JH, Kim DH, Hwang J, Lee G, Hyun JS, Heo ST, Choi JH, Kim M, Kim M, Kim SI, Eisenhut M, Kronbichler A, Shin JI. Dapsone as a potential treatment option for Henoch-Schönlein Purpura (HSP). Med Hypotheses 2017;108:42-5. [PMID: 29055398 DOI: 10.1016/j.mehy.2017.07.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
75 Sardana K, Bajaj S, Bose SK. Successful treatment of PAPA syndrome with minocycline, dapsone, deflazacort and methotrexate: a cost-effective therapy with a 2-year follow-up. Clin Exp Dermatol. 2019;44:577-579. [PMID: 30259545 DOI: 10.1111/ced.13792] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
76 Park HJ, Park JW, Kim SH, Choi SY, Kim HK, Jung CG, Yang MS, Kang DY, Cho MK, Kwon HS, Kang HR, Lee YW; Allergy Work Group of KAAACI. The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses. Expert Opin Drug Saf 2020;19:1349-56. [PMID: 32700588 DOI: 10.1080/14740338.2020.1796965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
77 Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment Modalities for Acne. Molecules 2016;21:E1063. [PMID: 27529209 DOI: 10.3390/molecules21081063] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 10.6] [Reference Citation Analysis]
78 Tavakolpour S. Current and future treatment options for pemphigus: Is it time to move towards more effective treatments? International Immunopharmacology 2017;53:133-42. [DOI: 10.1016/j.intimp.2017.10.027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
79 Karpel-Massler G, Kast RE, Siegelin MD, Dwucet A, Schneider E, Westhoff MA, Wirtz CR, Chen XY, Halatsch ME, Bolm C. Anti-glioma Activity of Dapsone and Its Enhancement by Synthetic Chemical Modification. Neurochem Res 2017;42:3382-9. [PMID: 28852934 DOI: 10.1007/s11064-017-2378-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
80 Moksha L, Halder N, Singh SB, Chawla R, Kumar A, Velpandian T. Pharmacoproteomic analysis of topical dapsone and prednisolone interventions in the aqueous humor of anterior uveitis. Exp Eye Res 2021;206:108534. [PMID: 33722510 DOI: 10.1016/j.exer.2021.108534] [Reference Citation Analysis]
81 Tangamornsuksan W, Lohitnavy M. Association Between HLA-B*1301 and Dapsone-Induced Cutaneous Adverse Drug Reactions: A Systematic Review and Meta-analysis. JAMA Dermatol 2018;154:441-6. [PMID: 29541744 DOI: 10.1001/jamadermatol.2017.6484] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 11.0] [Reference Citation Analysis]
82 Guglielmetti A, Gompertz M, Jahr C, Silva T, González S. Remission of refractory metastatic Crohn's disease achieved with dapsone. Int J Dermatol 2018;57:467-9. [PMID: 29318573 DOI: 10.1111/ijd.13885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 do Amaral LH, do Carmo FA, Amaro MI, de Sousa VP, da Silva LCRP, de Almeida GS, Rodrigues CR, Healy AM, Cabral LM. Development and Characterization of Dapsone Cocrystal Prepared by Scalable Production Methods. AAPS PharmSciTech 2018;19:2687-99. [DOI: 10.1208/s12249-018-1101-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
84 Poirot E, Vittinghoff E, Ishengoma D, Alifrangis M, Carneiro I, Hashim R, Baraka V, Mosha J, Gesase S, Chandramohan D, Gosling R. Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants. PLoS One 2015;10:e0142414. [PMID: 26599634 DOI: 10.1371/journal.pone.0142414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
85 Shukkoor AA, Thangavelu S, George NE, Priya S. Dapsone Hypersensitivity Syndrome (DHS): A Detrimental Effect of Dapsone? A Case Report. Curr Drug Saf 2019;14:37-9. [PMID: 30062974 DOI: 10.2174/1574886313666180731123232] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
86 Mizukami Y, Imanishi H, Tateishi C, Kaneshiro S, Sowa-Osako J, Ohsawa M, Tsuruta D. Successful treatment of pyostomatitis vegetans with ulcerative colitis using dapsone without systemic steroids. J Dermatol 2019;46:e316-7. [PMID: 30969436 DOI: 10.1111/1346-8138.14885] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
87 Colella MP, Orsi FA, Alves ECF, Delmoro GF, Yamaguti-Hayakawa GG, de Paula EV, Annichino-Bizzacchi JM. A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response. J Thromb Haemost 2021;19:2275-86. [PMID: 34018665 DOI: 10.1111/jth.15396] [Reference Citation Analysis]
88 Diaz-ruiz A, Roldan-valadez E, Ortiz-plata A, Mondragón-lozano R, Heras-romero Y, Mendez-armenta M, Osorio-rico L, Nava-ruiz C, Ríos C. Dapsone improves functional deficit and diminishes brain damage evaluated by 3-Tesla magnetic resonance image after transient cerebral ischemia and reperfusion in rats. Brain Research 2016;1646:384-92. [DOI: 10.1016/j.brainres.2016.06.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
89 Fernández-Villa D, Aguilar MR, Rojo L. Folic Acid Antagonists: Antimicrobial and Immunomodulating Mechanisms and Applications. Int J Mol Sci 2019;20:E4996. [PMID: 31601031 DOI: 10.3390/ijms20204996] [Cited by in Crossref: 25] [Cited by in F6Publishing: 17] [Article Influence: 12.5] [Reference Citation Analysis]
90 Cé R, Marchi JG, Bergamo VZ, Fuentefria AM, Lavayen V, Guterres SS, Pohlmann AR. Chitosan-coated dapsone-loaded lipid-core nanocapsules: Growth inhibition of clinical isolates, multidrug-resistant Staphylococcus aureus and Aspergillus ssp. Colloids and Surfaces A: Physicochemical and Engineering Aspects 2016;511:153-61. [DOI: 10.1016/j.colsurfa.2016.09.086] [Cited by in Crossref: 28] [Cited by in F6Publishing: 14] [Article Influence: 5.6] [Reference Citation Analysis]
91 Rajendran ND, Mookan N, Samuel I, Mookan SB, Munusamy G, Gurudeeban S, Kaliamurthi S. A theoretical study of chemical bonding and topological and electrostatic properties of the anti-leprosy drug dapsone. J Mol Model 2020;26:138. [PMID: 32415338 DOI: 10.1007/s00894-020-04393-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
92 Eisendle K, Thuile T, Deluca J, Pichler M. Surgical Treatment of Pyoderma Gangrenosum with Negative Pressure Wound Therapy and Skin Grafting, Including Xenografts: Personal Experience and Comprehensive Review on 161 Cases. Adv Wound Care (New Rochelle) 2020;9:405-25. [PMID: 32320362 DOI: 10.1089/wound.2020.1160] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 9.0] [Reference Citation Analysis]
93 Cabras M, Carrozzo M, Gambino A, Broccoletti R, Sciascia S, Baldovino S, Arduino PG. Value of colchicine as treatment for recurrent oral ulcers: A systematic review. J Oral Pathol Med 2020;49:731-40. [DOI: 10.1111/jop.13020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
94 Searle T, Al-Niaimi F, Ali FR. Dapsone for acne: Still in use after half a century! J Cosmet Dermatol 2021;20:2036-9. [PMID: 33600049 DOI: 10.1111/jocd.14011] [Reference Citation Analysis]
95 Gibson M, Rogers CL, Murrell DF. Successful dapsone therapy in inherited epidermolysis bullosa. J Eur Acad Dermatol Venereol 2020;34:e333-4. [PMID: 32065464 DOI: 10.1111/jdv.16301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
96 Braun DE, Krüger H, Kahlenberg V, Griesser UJ. Molecular Level Understanding of the Reversible Phase Transformation between Forms III and II of Dapsone. Cryst Growth Des 2017;17:5054-60. [PMID: 30337848 DOI: 10.1021/acs.cgd.7b01089] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
97 Gonzalez-Benavides N, Vera-Cabrera L, Sanchez-Meza E, Ocampo-Candiani J, Welsh O. Diaminodiphenyl-sulphone: in vitro activity alone and in combination with other antimicrobials against 30 strains of Nocardia brasiliensis. J Eur Acad Dermatol Venereol 2019;33:e395-6. [PMID: 31063602 DOI: 10.1111/jdv.15660] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
98 Oak AS, Seminario-Vidal L, Sami N. Treatment of antiviral-resistant recurrent erythema multiforme with dapsone. Dermatol Ther 2017;30. [PMID: 27860166 DOI: 10.1111/dth.12449] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
99 Bardazzi F, Loi C, Chessa Marco A, Di Altobrando A, Filippi F, Lacava R, Viviani F, Balestri R, Leuzzi M, Sacchelli L. Therapeutic approaches and targets for treatment of autoimmune bullous diseases. Dermatol Ther 2021;:e15032. [PMID: 34145701 DOI: 10.1111/dth.15032] [Reference Citation Analysis]
100 Hofman K, Liu N, Manolikakes G. Radicals and Sulfur Dioxide: A Versatile Combination for the Construction of Sulfonyl‐Containing Molecules. Chem Eur J 2018;24:11852-63. [DOI: 10.1002/chem.201705470] [Cited by in Crossref: 126] [Cited by in F6Publishing: 92] [Article Influence: 42.0] [Reference Citation Analysis]
101 Chasset F, Francès C. Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review. Drugs 2019;79:1199-215. [DOI: 10.1007/s40265-019-01151-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
102 Geyfman M, Debabov D, Poloso N, Alvandi N. Mechanistic insight into the activity of a sulfone compound dapsone on Propionibacterium (Newly Reclassified as Cutibacterium ) Acnes- mediated cytokine production. Exp Dermatol 2019;28:190-7. [DOI: 10.1111/exd.13869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
103 Choi JH, Lee DH, Song WJ, Choi M, Kwon JW, Kim GW, Kim MH, Kim MA, Kim MH, Kim BK, Kim S, Kim JS, Kim JE, Kim JY, Kim JH, Kim HJ, Kim HO, Kim HB, Roh JY, Park KH, Park KY, Park HK, Park H, Bae JM, Byun JY, Song DJ, Ahn YM, Lee SE, Lee YB, Lee JS, Lee JH, Lim KH, Youn SW, Chang YS, Jeon YH, Jeon J, Jue MS, Choi SH, Hur GY, Lim DH, Ye YM, Park YM. The KAAACI/KDA Evidence-Based Practice Guidelines for Chronic Spontaneous Urticaria in Korean Adults and Children: Part 2. Management of H1-Antihistamine-Refractory Chronic Urticaria. Allergy Asthma Immunol Res 2020;12:750-70. [PMID: 32638557 DOI: 10.4168/aair.2020.12.5.750] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
104 Roman C, Dima B, Muyshont L, Schurmans T, Gilliaux O. Indications and efficiency of dapsone in IgA vasculitis (Henoch-Schonlein purpura): case series and a review of the literature. Eur J Pediatr 2019;178:1275-81. [PMID: 31230197 DOI: 10.1007/s00431-019-03409-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
105 Lee JH, Choi SH, Lee CJ, Oh SS. Recovery of Dementia Syndrome following Treatment of Brain Inflammation. Dement Geriatr Cogn Dis Extra 2020;10:1-12. [PMID: 32158462 DOI: 10.1159/000504880] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
106 Dejban P, Rahimi N, Takzare N, Jahansouz M, Haddadi N, Dehpour AR. Beneficial effects of dapsone on ischemia/reperfusion injury following torsion/detorsion in ipsilateral and contralateral testes in rat. Theriogenology 2019;140:136-42. [DOI: 10.1016/j.theriogenology.2019.08.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
107 Kramer P, Krieg S, Kelm H, Manolikakes G. Manganese( iii ) acetate-mediated direct C(sp 2 )–H-sulfonylation of enamides with sodium and lithium sulfinates. Org Biomol Chem 2019;17:5538-44. [DOI: 10.1039/c9ob00825j] [Cited by in Crossref: 17] [Article Influence: 8.5] [Reference Citation Analysis]
108 Abramovits W. Dapsone in Dermatology. In: Yamauchi PS, editor. Biologic and Systemic Agents in Dermatology. Cham: Springer International Publishing; 2018. pp. 517-24. [DOI: 10.1007/978-3-319-66884-0_44] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Khazalpour S, Nematollahi D, Ahmad A, Dowlati B. Electroreductive nucleophile acceptor generation. Electrochemical synthesis of N-(4-(dimethylamino)phenyl)benzenesulfonamide. Electrochimica Acta 2015;180:909-13. [DOI: 10.1016/j.electacta.2015.09.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
110 Doolan BJ, Cranwell WC, Nicolopoulos J, Dolianitis C. Topical dapsone gel for treatment of axillary subcorneal pustular dermatosis. J Dermatol 2019;46. [DOI: 10.1111/1346-8138.14953] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
111 Ohashi T, Matsumura N, Yamamoto T. Successful treatment with dapsone for lupus profundus accompanied by xanthomatous reaction. Clin Exp Dermatol 2019;44:e3-4. [PMID: 30240040 DOI: 10.1111/ced.13781] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Chaves LL, Patriota Y, Soares-Sobrinho JL, Vieira ACC, Lima SAC, Reis S. Drug Delivery Systems on Leprosy Therapy: Moving Towards Eradication? Pharmaceutics 2020;12:E1202. [PMID: 33322356 DOI: 10.3390/pharmaceutics12121202] [Reference Citation Analysis]
113 Salahifar E, Nematollahi D. Electrochemical generation of a Michael acceptor: a green method for the synthesis of 4-amino-3-(phenylsulfonyl)diphenylamine derivatives. New J Chem 2015;39:3852-8. [DOI: 10.1039/c5nj00087d] [Cited by in Crossref: 10] [Article Influence: 1.7] [Reference Citation Analysis]
114 Franciosi AN, Ralph J, O'Farrell NJ, Buckley C, Gulmann C, O'Kane M, Carroll TP, McElvaney NG. Alpha-1 antitrypsin deficiency-associated panniculitis. J Am Acad Dermatol 2021:S0190-9622(21)00232-2. [PMID: 33516773 DOI: 10.1016/j.jaad.2021.01.074] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
115 Zhan R, Zhao M, Zhou T, Chen Y, Yu W, Zhao L, Zhang T, Wang H, Yang H, Jin Y, He Q, Yang X, Guo X, Willard B, Pan B, Huang Y, Chen Y, Chui D, Zheng L. Dapsone protects brain microvascular integrity from high-fat diet induced LDL oxidation. Cell Death Dis 2018;9:683. [PMID: 29880899 DOI: 10.1038/s41419-018-0739-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
116 van Straalen KR, Schneider-Burrus S, Prens EP. Current and future treatment of hidradenitis suppurativa. Br J Dermatol 2020;183:e178-87. [PMID: 29981245 DOI: 10.1111/bjd.16768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
117 Ezhilarasan D. Dapsone-induced hepatic complications: it's time to think beyond methemoglobinemia. Drug Chem Toxicol 2021;44:330-3. [PMID: 31631707 DOI: 10.1080/01480545.2019.1679829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
118 Heineke MH, van der Steen LPE, Korthouwer RM, Hage JJ, Langedijk JPM, Benschop JJ, Bakema JE, Slootstra JW, van Egmond M. Peptide mimetics of immunoglobulin A (IgA) and FcαRI block IgA-induced human neutrophil activation and migration. Eur J Immunol 2017;47:1835-45. [PMID: 28736835 DOI: 10.1002/eji.201646782] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
119 Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F, Abbasi A, Dehpour AR. Protective effect of dapsone against renal ischemia-reperfusion injury in rat. Immunopharmacol Immunotoxicol 2020;42:272-9. [PMID: 32321337 DOI: 10.1080/08923973.2020.1755308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
120 Leccia MT, Auffret N, Poli F, Claudel JP, Corvec S, Dreno B. Topical acne treatments in Europe and the issue of antimicrobial resistance. J Eur Acad Dermatol Venereol 2015;29:1485-92. [PMID: 25677763 DOI: 10.1111/jdv.12989] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
121 El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM. Bilosomes as a novel carrier for the cutaneous delivery for dapsone as a potential treatment of acne: preparation, characterization and in vivo skin deposition assay. J Liposome Res 2020;30:1-11. [PMID: 31010357 DOI: 10.1080/08982104.2019.1577256] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]